Showing results (1181-1190 of 1,405) with videos related to

Sort By:
Pageof 141
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|April 19, 2018
Combination Therapy with Peritoneal Dialysis and Hemodialysis from the Initiation of Renal Replacement Therapy Preserves Residual Renal Function and Serum AlbuminAtsushi Ueda, Kei Nagai, Aki Hirayama, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 29, 2000
The effect of N-acetylglucosamine as a substrate for in vitro synthesis of glycosaminoglycans by human peritoneal mesothelial cells and fibroblastsA Breborowicz, M Kuzlan-Pawlaczyk, K Wieczorowska-Tobis, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 29, 2000
Sphingosine and sphinganine levels in human mesothelial cells in vitro as a potential index of signal transduction pathways impacted by microbes and osmolalityD M Nowak, I Ansell, J T Hjelle, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 29, 2000
In vitro and in vivo generation and kinetics of glycosylation products in peritoneal dialysis effluentsS Yokota, K Kumano, T Hyodo, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 29, 2000
Effect of intraperitoneal immunoglobulin infusion on neutrophil function in CAPD children with and without peritonitisS Akman, A G Güven, S Ince, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 29, 2000
Peritoneal penetration of amphotericin B lipid complex and fluconazole in a pediatric patient with fungal peritonitisD L Blowey, U C Garg, G L Kearns, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 29, 2000
Improvement of glycemic control by CAPD with intraperitoneal insulin in a child with IDDM and ESRDJ T Flynn, D B Kershaw, A B Sedman, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|October 25, 2000
Peritoneal dialysis in adult patients without end-stage renal diseaseR Mehrotra
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|October 25, 2000
Serum level of vascular endothelial growth factor is influenced by erythropoietin treatment in peritoneal dialysis patients. (Grupo de Estudios Peritoneales de Madrid)G del Peso, R Selgas, M A Bajo, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|October 25, 2000
Compliance with subcutaneous erythropoietin in peritoneal dialysis patientsP Nicoletta, J Bernardini, C Dacko, et al.
Pageof 141